BSTE Biosite (MM)

SAN DIEGO, Jan. 6 /PRNewswire-FirstCall/ -- Biosite Incorporated (NASDAQ:BSTE) today announced that Kim Blickenstaff, chairman and chief executive officer, and Ken Buechler, president and chief scientific officer, will discuss the Company's operating environment, new and potential products and the company's research and development activities at the 24th Annual JP Morgan Healthcare Conference. Biosite's presentation will take place Wednesday, January 11, 2006, at 8:00 a.m. Pacific. The conference is to be held at the Westin St. Francis Hotel in San Francisco. A link to the live audio webcast can be accessed through the Biosite website, http://www.biosite.com/. The Biosite presentation will be archived on the website until February 2, 2006 in the Investor and Media section under Events Calendar. About Biosite Incorporated Biosite Incorporated is a leading bio-medical company commercializing proteomics discoveries for the advancement of medical diagnosis. The Company's products contribute to improvements in medical care by aiding physicians in the diagnosis of critical diseases and health conditions. Biosite's Triage(R) rapid diagnostics are used in approximately 50 percent of U.S. hospitals and in more than 50 international markets. Information on Biosite can be found at http://www.biosite.com/. Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered trademarks of Biosite Incorporated. The Company's logo is a trademark of Biosite Incorporated. DATASOURCE: Biosite Incorporated CONTACT: Nadine Padilla, Vice President, Corporate and Investor Relations of Biosite Incorporated, +1-858-805-2820, Web site: http://www.biosite.com/ Company News On-Call: http://www.prnewswire.com/comp/116737.html

Copyright